Form 8-K BIND Therapeutics, Inc For: Aug 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
BIND Therapeutics (BIND) Reports In-Line Q2 Loss
August 6, 2015 7:59 AM EDTBIND Therapeutics (NASDAQ: BIND) reported Q2 EPS of ($0.51), in-line with the analyst estimate of ($0.51). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.88 million.
For earnings history and earnings-related data on BIND Therapeutics (BIND) click here.
... More